Trials / Completed
CompletedNCT00234845
Adalimumab in Combination With Methotrexate vs Methotrexate Alone in Early Rheumatoid Arthritis
A Multi-Centre Randomized, Double-Blind Study Comparing Adalimumab (D2E7) Plus Methotrexate With Placebo Plus Methotrexate on Work Disability in Subjects With Early Rheumatoid Arthritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 148 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate the effectiveness of adalimumab in combination with methotrexate compared to methotrexate alone on work disability in subjects with early rheumatoid arthritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | adalimumab | |
| DRUG | methotrexate |
Timeline
- Start date
- 2003-03-01
- First posted
- 2005-10-10
- Last updated
- 2007-08-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00234845. Inclusion in this directory is not an endorsement.